Business · 13/02/2019

FDA Clears LOTRIMIN (Clotrimazole) Topical Solution for Continued Sale

The US Food and Drug Administration (FDA) has ruled that LOTRIMIN (clotrimazole) 1% topical solution was not withdrawn from the market due to safety or efficacy concerns, allowing the agency to continue approving abbreviated new drug applications (ANDAs) for the product.